IL43022A0 - An oral pharmaceutical composition containing cholestyramine coacervate - Google Patents
An oral pharmaceutical composition containing cholestyramine coacervateInfo
- Publication number
- IL43022A0 IL43022A0 IL43022A IL4302273A IL43022A0 IL 43022 A0 IL43022 A0 IL 43022A0 IL 43022 A IL43022 A IL 43022A IL 4302273 A IL4302273 A IL 4302273A IL 43022 A0 IL43022 A0 IL 43022A0
- Authority
- IL
- Israel
- Prior art keywords
- coacervate
- pharmaceutical composition
- composition containing
- oral pharmaceutical
- containing cholestyramine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28571972A | 1972-09-01 | 1972-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL43022A0 true IL43022A0 (en) | 1974-01-14 |
IL43022A IL43022A (en) | 1976-07-30 |
Family
ID=23095432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL43022A IL43022A (en) | 1972-09-01 | 1973-08-20 | An oral pharmaceutical composition containing cholestyramine coacervate |
Country Status (7)
Country | Link |
---|---|
CA (1) | CA1014472A (en) |
DE (1) | DE2344090A1 (en) |
FR (1) | FR2197592B1 (en) |
GB (1) | GB1446352A (en) |
IL (1) | IL43022A (en) |
NL (1) | NL7311319A (en) |
ZA (1) | ZA736016B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4914084A (en) * | 1984-05-09 | 1990-04-03 | Synthetic Blood Corporation | Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body |
US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
US4804548A (en) * | 1984-10-05 | 1989-02-14 | Warner-Lambert Company | Novel sweetener delivery systems |
US4828857A (en) * | 1984-10-05 | 1989-05-09 | Warner-Lambert Company | Novel sweetener delivery systems |
US4818539A (en) * | 1985-02-05 | 1989-04-04 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US4790991A (en) * | 1985-02-05 | 1988-12-13 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US4747881A (en) * | 1985-02-05 | 1988-05-31 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US4843098A (en) * | 1985-02-05 | 1989-06-27 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US4851392A (en) * | 1985-02-05 | 1989-07-25 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
IT1190349B (en) * | 1986-06-16 | 1988-02-16 | Prodotti Formenti Srl | PHARMACEUTICAL COMPOSITIONS WITH SEQUESTRANT ACTIVITY OF BILE ACIDS CONTAINING COLESTYRAMINE AS THE ACTIVE INGREDIENT, AND PROCEDURE TO PREPARE THEM |
GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
CA1313135C (en) * | 1987-02-09 | 1993-01-26 | The Dow Chemical Company | Cholestyramine composition and process for its preparation |
US5167965A (en) * | 1987-02-09 | 1992-12-01 | The Dow Chemical Company | Palatable cholestyramine granules, tablets and methods for preparation thereof |
EP0349103B1 (en) * | 1988-05-04 | 1992-11-25 | Smith Kline & French Laboratories Limited | Chewable tablet |
US4931280A (en) * | 1988-06-13 | 1990-06-05 | Basf K & F Corporation | Edible, baked compositions containing cholestyramine |
US5275823A (en) * | 1989-04-27 | 1994-01-04 | Smith Kline & French Laboratories Ltd. | Pharmaceutical compositions |
US5102664A (en) * | 1989-07-19 | 1992-04-07 | Day Charles E | Good-tasting gritty drug formulations |
KR100221396B1 (en) * | 1990-12-20 | 1999-09-15 | 데이비드 엠 모이어 | Composition of plantain and cholestyramine with improved aesthetics |
AU3812893A (en) * | 1992-03-20 | 1993-10-21 | Procter & Gamble Company, The | Anion exchange resin compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3499960A (en) * | 1965-01-25 | 1970-03-10 | Merck & Co Inc | Palatable coated particles of an anion exchange resin |
-
1973
- 1973-08-16 NL NL7311319A patent/NL7311319A/xx not_active Application Discontinuation
- 1973-08-20 IL IL43022A patent/IL43022A/en unknown
- 1973-08-28 GB GB4039973A patent/GB1446352A/en not_active Expired
- 1973-08-29 FR FR7331221A patent/FR2197592B1/fr not_active Expired
- 1973-08-30 CA CA179,971A patent/CA1014472A/en not_active Expired
- 1973-08-31 ZA ZA00736016A patent/ZA736016B/en unknown
- 1973-08-31 DE DE19732344090 patent/DE2344090A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE2344090A1 (en) | 1974-03-21 |
FR2197592A1 (en) | 1974-03-29 |
FR2197592B1 (en) | 1976-08-13 |
NL7311319A (en) | 1974-03-05 |
GB1446352A (en) | 1976-08-18 |
AU5946073A (en) | 1975-02-27 |
CA1014472A (en) | 1977-07-26 |
IL43022A (en) | 1976-07-30 |
ZA736016B (en) | 1975-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL42430A0 (en) | Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them | |
IL43022A0 (en) | An oral pharmaceutical composition containing cholestyramine coacervate | |
ZA731808B (en) | Pharmaceutical compositions | |
ZA733811B (en) | Pharmaceutical compositions containing cysteine | |
ZA732438B (en) | Pharmaceutical composition | |
IL43837A0 (en) | New aminophenyl-ethanolamines and corresponding oxazolidines,their preparation and pharmaceutical compositions containing them | |
IL43722A0 (en) | Novel 2-aminomethyleneindanones and pharmaceutical compositions containing them | |
IL43766A0 (en) | Pharmaceutical compositions containing bis-phenolalkane derivatives | |
IL42429A0 (en) | 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them | |
AU5561973A (en) | Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine | |
IE38280L (en) | Pharmaceutical composition containing a 1,2,4-triazole¹derivative | |
MY7700009A (en) | Pharmaceutical compositions containing bischromonyloxy compounds | |
ZA734996B (en) | Oral composition | |
PH11231A (en) | Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them | |
AU5731773A (en) | 2-oxo-indoline compounds and pharmaceutical compositions | |
ZA731012B (en) | Pharmaceutical compositions | |
IL40747A0 (en) | 1-phenyl-3-hydroxy-3-methyl-triazenes,their preparation and pharmaceutical compositions containing them | |
IL42790A0 (en) | 4a-aryl-trans-decahydroisoquino-lines,their preparation and pharmaceutical compositions containing them | |
IL42613A0 (en) | Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them | |
ZA732439B (en) | Pharmaceutical composition | |
IL42560A0 (en) | 3-amino-pyrazol-5-ones and their salts their manufacture and pharmaceutical compositions containing them | |
IL41564A0 (en) | Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives | |
CY940A (en) | Pharmaceutical formulations | |
ZA734331B (en) | Pharmaceutical compositions | |
IL42509A0 (en) | Diisoquinolyl-dipyridyl-butanes,and their salts their manufacture and pharmaceutical compositions containing them |